Genetic Thrombosis Screening Test

Thrombosis DNA Analysis

According to the American Heart Association, Deep Vein Thrombosis (DVT) occurs in about 2 million Americans every year. More people suffer from DVT annually than heart attack and stroke. Up to 600,000 people are hospitalized in the U.S. each year for DVT. Fatal Pulmonary Embolism may be the most common preventable cause of hospital death in the United States . Thrombosis or DVT is a PREVENTABLE condition and a Thrombosis DNA Analysis can lead you to make lifestyle changes or to consider becoming a candidate for medication, possibly saving your life.

Of those who develop a Pulmonary Embolism (PE) from DVT, up to 200,000 will die each year. More people die in the United States from PE than breast cancer and AIDS combined. These significant statistics do not account for DVT related stroke or heart attack. DVT is the leading cause of maternal death during child birth.
However, using the power of genetic testing, a genetic test panel can examine a number of genetic factors that may indicate a predisposition to Thrombosis or blood clotting problems. These gene mutations combined with other factors such as smoking, frequent air travel, sustaining a sports injury, hospitalization – and, in the case of women, the use of oral contraceptives, hormone replacement therapy or pregnancy – could put an individual at a much higher risk of DVT. The more risk factors an individual has, the greater the likelihood of developing DVT.

For more information, or to order a genetic test for Thrombosis, visit the LabSafe website at http://www.labsafe.com/lab-tests/test/526/ or call LabSafe toll free at 1-888-333-LABS.

LabSafe Direct Lab Services - www.labsafe.com